FDA
-
-
-
-
-
-
-
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
-
-
-
-
-
-
-
Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers
-
-
-
-
-
-
-
Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KITâ„¢
-
-
-
-
-
-
-
Delcath Systems (DCTH) Appoints Vojislav Vukovic as Chief Medical Officer
-
-
-
-
-
-
-
Delcath Systems Announces Resumption of Interest-Only Period for Company's Debt Facility
-
-
-
-
-
-
-
Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch
-
251,409 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All